Urogen Pharma Ltd
NASDAQ:URGN

Watchlist Manager
Urogen Pharma Ltd Logo
Urogen Pharma Ltd
NASDAQ:URGN
Watchlist
Price: 23.535 USD -0.7%
Market Cap: 1.1B USD

Wall Street
Price Targets

URGN Price Targets Summary
Urogen Pharma Ltd

Wall Street analysts forecast URGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for URGN is 35.955 USD with a low forecast of 16.16 USD and a high forecast of 57.75 USD.

Lowest
Price Target
16.16 USD
31% Downside
Average
Price Target
35.955 USD
53% Upside
Highest
Price Target
57.75 USD
145% Upside
Urogen Pharma Ltd Competitors:
Price Targets
6160
Beigene Ltd
21% Upside
ADAG
Adagene Inc
440% Upside
IONS
Ionis Pharmaceuticals Inc
17% Upside
VRTX
Vertex Pharmaceuticals Inc
14% Upside
GILD
Gilead Sciences Inc
7% Upside
SBTX
SkinBioTherapeutics PLC
91% Upside
BMRN
Biomarin Pharmaceutical Inc
78% Upside
4587
PeptiDream Inc
111% Upside

Revenue
Forecast

Revenue Estimate
Urogen Pharma Ltd

The compound annual growth rate of Urogen Pharma Ltd's revenue for the next 3 years is 67%.

N/A
Past Growth
67%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Urogen Pharma Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Urogen Pharma Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is URGN's stock price target?
Price Target
35.955 USD

According to Wall Street analysts, the average 1-year price target for URGN is 35.955 USD with a low forecast of 16.16 USD and a high forecast of 57.75 USD.

What is Urogen Pharma Ltd's Revenue forecast?
Projected CAGR
67%

The compound annual growth rate of Urogen Pharma Ltd's revenue for the next 3 years is 67%.

Back to Top